Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SSM Health St. Louis Cord Blood Bank is a prominent public cord blood bank and the manufacturer of Allocord, an FDA-licensed hematopoietic progenitor cell (HPC) therapy. Allocord is derived from umbilical cord blood and is indicated for use in unrelated donor hematopoietic progenitor cell transplantation procedures in patients with disorders affecting the hematopoietic system. The organization specializes in the collection, processing, and cryopreservation of high-quality cord blood units under strict GMP standards. As one of the first public banks to receive FDA licensure for a cord blood product, it plays a vital role in providing life-saving cellular therapies for patients with leukemia, lymphoma, and various genetic metabolic disorders. The bank operates as part of the Be The Match network, facilitating transplants for patients globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allocord.